Results for dosage filler translation from Dutch to Italian

filler
filler

druk dosage
pressione dosaggio

'dosage compensation' (genetica)
compensazione genetica

gebruik de plamuur van wound filler.
usa il nuovo stucco riempiferita cosmetico.

stability testing requirements for new dosage forms
stability testing requirements for new dosage forms

en dan verzegelen we het weer met polymeer filler.
poi possiamo sigillarlo con un filamento di polimero.

modified release oral and transdermal dosage forms:
modified release oral and transdermal dosage forms:

quality of modified release dosage forms for veterinary use
quality of modified release dosage forms for veterinary use

zeg me dat je polymeer filler bij hebt. mijn favoriete merk.
ti prego, dimmi che hai portato un filamento di polimero.

comparison of three dosage regimens of ciprofloxacin in urinary tract infections.
comparison of three dosage regimens of ciprofloxacin in urinary tract infections.

richtsnoeren clinical investigation of new vaccines modified release oral and transdermal dosage forms:
linee guida clinical investigation of new vaccines modified release oral and transdermal dosage forms:

start of shelf-life of the finished dosage form quality of herbal medicinal products specifications:
start of shelf-life of the finished dosage form quality of herbal medicinal products specifications:

note for guidance on modified release oral and transdermal dosage forms: section ii (quality)
note for guidance on modified release oral and transdermal dosage forms: section ii (quality)

quality of water for pharmaceutical use quality of water for pharmaceutical use – revision quality of modified release dosage forms for veterinary use
quality of water for pharmaceutical use quality of water for pharmaceutical use – revision quality of modified release dosage forms for veterinary use ich q3c (m) maintenance document for guidance on impurities:

a. oral dosage forms; b. and transdermal dosage forms; section i (quality)
a. oral dosage forms; b. and transdermal dosage forms; section i (quality).

titel document in-use stability testing of veterinary medicinal products use of near infrared spectroscopy by the pharmaceutical industry modified release oral and transdermal dosage forms revision:
titolo del documento in-use stability testing of veterinary medicinal products use of near infrared spectroscopy by the pharmaceutical industry modified release oral and transdermal dosage forms revision:

adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino-conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino-conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms: